Mumbai, 2026

The Scientific Capital Table

40 people. One table. One question: 
How do we create a capital market for science?

RSVP

Read the Proposition

Date

5 October 2026

Venue

Nishith Desai Associates, 2nd Floor, 3 North Avenue, MakerMaxity, BKC, Mumbai

Seats

40, personally composed

Access

By invitation only

THE PREMISE

Science is producing assets faster than capital markets can finance them.

India is creating world-class scientific IP, datasets and development programs. AI now makes it possible to value scientific progress in real time. The question is no longer whether — buthow— to create a capital market for these assets.

"The problem is not a shortage of innovation; it is the absence of a mechanism to finance intangible scientific assets independently of the corporate wrapper."

$195.3B

India Bioeconomy 2030 Target

-48%

Private Cap Contraction (YoY)

THE STRUCTURAL FRICTION

Why Traditional VC Fails Deep Science Assets

01 / VOLATILITY

Binary & Lumpy Outcomes

Clinical trial readouts and regulatory milestones create step-function returns, not smooth revenue growth curves.

02 / BENCHMARKING

Thin Actuarial History

Lack of standardized historical comparables prevents institutional risk pricing and underwriting mechanisms.

03 / HORIZON

Long Duration to Liquidity

10–15 year scientific development lifecycles directly clash with standard 7–10 year venture fund mandates.

04 / INFORMATION

Researcher-Investor Gap

High technical complexity creates acute information asymmetry between scientific creators and capital allocators.

THE CAMPAIGN CONTINUUM

A Global Journey Towards a New Asset Class

Click any milestone to explore its strategic brief, participant focus, and structural outcomes.

STAGE 01 • DELHI

COMPLETED

The Proposition

Framing the legal & public market infrastructure for scientific assets.

Explore Brief

STAGE 02 • MUMBAI

OCT 5 • LIVE

The Market Table

40 decision-makers assembled at NDA BKC & Indian Accent.

Request Seat at Table

STAGE 03 • SINGAPORE

NEXT UP

The Network

Connecting Indian science assets to global RWA digital asset rails at TOKEN2049.

View Syndicate Brief

STAGE 04 • EXECUTION

OUTCOME

First Transactions

Issuing Scientific Asset Receipts (SARs) backed by live clinical datasets.

Read Pilot Mode

THE CONSTITUENCY

40 Seats. Five Pillars.

Curated to assemble the essential decision-makers needed to structure a scientific capital market.

Family Offices & Sovereign Allocators

Strategic Pharma & Biotech CEOs

Market Intermediaries & Advisory Leaders

Policy & Regulatory Voices

Global Digital Asset & RWA Protocols

CONVENING AGENDA

OCTOBER 5, 2026

14:00 – 18:30

Working Session

BKC, Mumbai, India. Closed-door legal & market architecture design.

19:00 – 19:45

Private Reception

Bayroute. Executive introductions & networking.

20:00 – 21:30

Founding Dinner

Multi-course culinary experience paired with strategic keynotes.

BY INVITATION ONLY

Request a Seat at The Scientific Capital Table

Participation is strictly limited to 40 primary decision-makers across Sovereign Funds, Family Offices, Biopharma CEOs, Market Intermediaries, and Policy Leaders.